Japanese
English
Home
About Us
Message from CEO
Our Mission
Our Business
Corporate Information
Leadership/ Governance
Access
Our Science
PRIME Technology
Application of Our Technology
Pipelines
Our Partners
IR
IR News
Management
Top Message
Corporate Governance
Disclosure Policy
Financial Highlights
IR Library
Financial Results
Presentation Materials
Securities Report
IR Materials
For Shareholders
Stock Overview
General Meeting of Shareholders
Stock Quotations
IR Calendar
IR FAQ
IR Contact
Disclaimer
Careers
Contact Us
Contact Us
Create the Future to Overcome Cancer
Notice from Noile
Notice From Noile about Impersonation Message (PDF)
News
2026/11/18
Research Findings of “Swift PRIME CAR-T”, Enabling Shortened Manufacturing Time, Presented at the Annual Meeting of the Japanese Society for Immunology
2026/11/16
Financial Results for the Nine Months Ended September 30, 2026 Under Japanese GAAP (Non-consolidated)
2026/11/09
A New Patent for Technology under Development Granted in Japan
2026/10/26
Financing through the Issuance of Stock Acquisition Rights, Supplementary explanatory materials (Japanese version already released on September 18)
2026/10/26
Notice Regarding the Issuance of Noile-Immune Biotech Inc.'s 14th Series Stock Acquisition Rights (with Exercise Price Adjustment Clause) through Third-Party Allotment (Japanese version already released on September 18)
Details